We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3626:TSETIS Inc. Analysis

Data as of 2026-06-17 - not real-time

¥3,120.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

TIS Inc. (3626.T) is currently trading at ¥3,120, well below its 20‑day (¥3,348) and 50‑day (¥3,445) simple moving averages, indicating a short‑term bearish bias. The 14‑day RSI sits at 37.8, flirting with oversold territory but not yet triggering a reversal signal. A bearish MACD crossover (line –92.2 vs signal –63.1) and a widening negative histogram reinforce the downtrend. Volume has been tapering, and the 30‑day volatility is elevated at roughly 44%, suggesting price swings may remain pronounced. Nonetheless, the broader market mood is one of Extreme Greed (Fear‑Greed Index 88.5), which could provide a tailwind for risk‑on assets like Japanese tech stocks.
Fundamentally, TIS appears substantially undervalued: its trailing PE of 15.2 is far below the industry average of 37, and the discounted cash‑flow model pegs a fair value near ¥3,807, implying roughly 27% upside. The company delivers solid profitability with a 7.8% net margin, 14% ROE and 8.6% ROA, while maintaining a low debt‑to‑equity ratio (≈11%) and a cash pile of ¥97.5 bn. Revenue is growing modestly at 3.3% YoY, and forward EPS expectations lift the forward PE to 13.4, hinting at continued earnings momentum. Dividend sustainability looks robust, with a 2.88% yield, a payout ratio under 40%, and ample operating cash flow. Given the blend of attractive valuation, strong cash generation, and modest leverage, the stock presents a compelling value case despite its near‑term technical weakness.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish technical indicators (price below SMA, negative MACD)
  • Proximity to recent support level around ¥3,084
  • Elevated 30‑day volatility (~44%)

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF‑derived fair value suggests ~27% upside
  • Strong cash flow and low leverage
  • Attractive dividend yield with sustainable payout

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Consistently low PE relative to industry
  • Stable earnings growth and ROE ~14%
  • Long‑term dividend sustainability and cash generation

Key Metrics & Analysis

Financial Health

Revenue Growth3.30%
Profit Margin7.82%
P/E Ratio15.2
ROE14.01%
ROA8.59%
Debt/Equity11.32
P/B Ratio2.1
Op. Cash Flow¥81.4B
Free Cash Flow¥48.3B
Industry P/E37.0

Technical Analysis

TrendBearish
RSI37.8
Support¥3,084.00
Resistance¥3,650.00
MA 20¥3,348.15
MA 50¥3,445.02
MA 200¥4,294.43
MACDBearish
VolumeDecreasing
Fear & Greed Index88.5

Valuation

Fair Value¥3,807.04
Target Price¥3,954.17
Upside/Downside26.74%
GradeUndervalued
TypeValue
Dividend Yield2.88%

Risk Assessment

Beta0.55
Volatility44.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.